NOS2 Gene Hypertension susceptibility to Genetic Test
Components: NOS2 Gene Hypertension susceptibility to Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Vascular Diseases
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for NOS2 Gene Hypertension, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NOS2 Gene Hypertension, susceptibility to NGS Genetic DNA Test gene NOS2
Test Details:
The NOS2 gene is involved in the production of nitric oxide synthase, an enzyme that helps regulate blood pressure by controlling the dilation of blood vessels. Variations in the NOS2 gene have been associated with hypertension, or high blood pressure.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. This technology enables researchers to identify variations or mutations in genes, including the NOS2 gene, that may be associated with specific conditions or diseases.
In the context of hypertension, NGS genetic testing can be used to identify variations in the NOS2 gene that may increase an individual’s susceptibility to developing high blood pressure. By analyzing the entire gene or specific regions of interest, researchers can determine if there are any genetic factors that may contribute to an individual’s risk of hypertension.
NGS genetic testing for hypertension susceptibility can provide valuable information for both individuals and healthcare providers. It can help identify individuals who may have an increased risk of developing hypertension, allowing for early intervention and lifestyle modifications to prevent or manage the condition. Additionally, this type of testing can contribute to a better understanding of the genetic basis of hypertension and potentially lead to the development of more targeted therapies in the future.
Test Name | NOS2 Gene Hypertension susceptibility to Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Vascular Diseases |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for NOS2 Gene Hypertension, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NOS2 Gene Hypertension, susceptibility to NGS Genetic DNA Test gene NOS2 |
Test Details |
The NOS2 gene is involved in the production of nitric oxide synthase, an enzyme that helps regulate blood pressure by controlling the dilation of blood vessels. Variations in the NOS2 gene have been associated with hypertension, or high blood pressure. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. This technology enables researchers to identify variations or mutations in genes, including the NOS2 gene, that may be associated with specific conditions or diseases. In the context of hypertension, NGS genetic testing can be used to identify variations in the NOS2 gene that may increase an individual’s susceptibility to developing high blood pressure. By analyzing the entire gene or specific regions of interest, researchers can determine if there are any genetic factors that may contribute to an individual’s risk of hypertension. NGS genetic testing for hypertension susceptibility can provide valuable information for both individuals and healthcare providers. It can help identify individuals who may have an increased risk of developing hypertension, allowing for early intervention and lifestyle modifications to prevent or manage the condition. Additionally, this type of testing can contribute to a better understanding of the genetic basis of hypertension and potentially lead to the development of more targeted therapies in the future. |